Drugs that contain Desvenlafaxine Succinate
1. Drug name - PRISTIQ
| Patent Number | Company | Patent Title | Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These patents protects the active chemical substance. Only patent owner can launch products that use this active substance. | ||||
| US6673838 | PF PRISM CV | Succinate salt of O-desmethyl-venlafaxine |
Mar, 2022
(6 months ago) | |
| US8269040 | PF PRISM CV | Derivatives of venlafaxine and methods of preparing and using the same |
Jul, 2027
(4 years from now) | |
| CN100567253C | PF PRISM CV | O-Desmethyl-Venlafaxine Succinate |
Feb, 2022
(7 months ago) | |
| CN1501909A | PF PRISM CV | A New O-Demethyl-Venlafaxine Succinate |
Feb, 2022
(7 months ago) | |
| IN201649B | PF PRISM CV | Novel Succinate Salt Of O-Desmethyl- Venlafaxine |
Feb, 2022
(7 months ago) | |
| IN200301015P2 | PF PRISM CV | Novel Succinate Salt Of O-Desmethyl-Venlafaxine |
Feb, 2022
(7 months ago) | |
| EP1466889B1 | PF PRISM CV | O-Desmethylvenlafaxine Succinate |
Mar, 2020
(2 years ago) | |
| EP1466889A1 | PF PRISM CV | O-Desmethylvenlafaxine Succinate |
Mar, 2020
(2 years ago) | |
| EP1360169B2 | PF PRISM CV | Succinate Salt Of O-Desmethyl-Venlafaxine |
Feb, 2022
(7 months ago) | |
| EP1360169A2 | PF PRISM CV | Succinate Salt Of O-Desmethyl-Venlafaxine |
Feb, 2022
(7 months ago) | |
| EP1360169B1 | PF PRISM CV | Succinate Salt Of O-Desmethyl-Venlafaxine |
Feb, 2022
(7 months ago) | |
Treatment: NA
Dosage: TABLET, EXTENDED RELEASE;ORAL
More Information on Dosage
| Strength | Dosage | Availability |
|---|---|---|
| EQ 25MG BASE | TABLET, EXTENDED RELEASE;ORAL | Prescription |
| EQ 50MG BASE | TABLET, EXTENDED RELEASE;ORAL | Prescription |
| EQ 100MG BASE | TABLET, EXTENDED RELEASE;ORAL | Prescription |
availability in other generic markets.
Click on the highlighted region to filter.